Equine Cushing's Disease: A Clinical Update

Author(s):  Bliss George

Issue:  Sep/Oct 2007 - Veterinary Compounding
View All Articles in Issue

Abstract:  The Department of Pharmacology at the North Carolina State University College of Veterinary Medicine is currently conducting stability studies of oral suspensions of pergolide for the treatment of equine Cushing’s disease. While those results are not available at this time, this paper summarizes the results of a literature search on possible clinical treatments for equine Cushing’s and is intended to provide insight into the pathophysiology of the disease. Pharmacological options for treatment of equine Cushing’s are discussed.

Related Keywords: horses, veterinary compounding, Cushing's disease, endocrine disorders, pergolide, formulations, cortisol, hypercortisolism, PPID, pituitary pars intermedia dysfunction, adrenal disorders, pituitary disorders, cyproheptadine, serotonin antagonist, ACTH, trilostane, 3-beta hydroxysteroid dehydrogenase inhibitor, literature review

Related Categories: FORMULATIONS, VETERINARY, ENDOCRINOLOGY/HORMONES/ MENOPAUSE/ANDROPAUSE, NEUROLOGY

Purchase this article for download in electronic PDF format from IJPC at for $75 at:
https://ijpc.com/Abstracts/Abstract.cfm?ABS=2650

Search the entire IJPC archive by keyword, topic, or issue at:
https://ijpc.com/Products